Skip to main content
. 2018 Jun 28;17:29. doi: 10.1186/s12941-018-0281-x

Fig. 1.

Fig. 1

A flow diagram of proton pump inhibitor-based therapy. Patients who underwent clarithromycin susceptibility testing were treated by either PPI-AC or PPI-AM regimen. PPI-AC therapy was chosen for empirical therapy. PPI-AC proton pump inhibitor with amoxicillin and clarithromycin, PPI-AM proton pump inhibitor with amoxicillin and metronidazole